Your browser doesn't support javascript.
loading
Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019.
Bhatnagar, Vishal; Hudgens, Stacie; Piault-Louis, Elisabeth; Jones, Lee; Beaver, Julia A; Lyerly, H Kim; Reaman, Gregory; Fleming, Thomas; Kluetz, Paul G.
Afiliação
  • Bhatnagar V; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Hudgens S; Quantitative Science, Clinical Outcomes Solutions, Tucson, Arizona, USA.
  • Piault-Louis E; Genentech, Inc., South San Francisco, California, USA.
  • Jones L; Patient Representative, Arlington, Virginia, USA.
  • Beaver JA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Lyerly HK; Duke University, Durham, North Carolina, USA.
  • Reaman G; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Fleming T; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Oncologist ; 25(10): 819-821, 2020 10.
Article em En | MEDLINE | ID: mdl-32463153

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncologia / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncologia / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article